Biovica International AB (9II) Stock Price & News

All values in SEK	Oct 2025	Jan 2026	Apr 2026	Jul 2026
Revenue	2.68M	3.29M	4.92M	4.04M
Cost of goods sold	-431.00K	48.00K	255.00K	595.00K
Cost of revenue	-431.00K	48.00K	255.00K	595.00K
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	16.00M	19.06M	20.66M	22.13M
Operating expense	18.17M	21.14M	22.81M	23.89M
Total operating expenses	17.74M	21.18M	23.06M	24.49M
Operating income	-15.06M	-17.89M	-18.14M	-20.45M
Other non operating income	94.00K	113.00K	-419.00K	112.00K
EBT including unusual items	-14.98M	-17.69M	-17.70M	-20.29M
EBT excluding unusual items	-14.98M	-17.69M	-17.70M	-20.29M
Income tax expense	128.00K	161.00K	1.42M	-141.00K
Effective tax rate	-0.85%	-0.91%	-8.05%	0.69%
Other operating expenses	32.00K	49.00K	156.00K	98.00K
Net income	-15.11M	-17.85M	-19.12M	-20.15M
Net profit margin	-564.69%	-541.96%	-388.66%	-498.32%
Earnings per share	-0.06	-0.06	-	-
Interest and investment income	56.00K	136.00K	112.00K	175.00K
Interest expense	-74.00K	-49.00K	-37.00K	-129.00K
Net interest expenses	-18.00K	87.00K	75.00K	46.00K
Depreciation and amortization charges	2.13M	2.02M	2.00M	1.67M
EBITDA	-12.93M	-15.87M	-16.15M	-18.78M
Gain or loss from assets sale	-	-	-	-

Finance